1-12 of 12
Lynn Malec
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Unmet Needs, Factor Consumption, and Healthcare Resource Use Among People with Hemophilia a: Real-World Analysis of the Adelphi Hemophilia Disease Specific Programme TM

Lynn Malec, Davide Matino, Kieran Wynne-Cattanach, Chris Blazos, Duygu Bozkaya, Anne-Laure Tardy, Sylvie Bozzi, Jennifer Dumont
Journal: Blood
Blood (2024) 144 (Supplement 1): 3973.
https://doi.org/10.1182/blood-2024-193803
Published: 2024
Journal Articles

Combatt HMB-Recon: Combination Therapy in Adolescents to Treat Heavy Menstrual Bleeding-Review of Charts to Observe Treatment Patterns

Lauren E. Amos, Hung-Wen Yeh, Ayesha Zia, Meera Chitlur, Lynn Malec, Allison P. Wheeler
Journal: Blood
Blood (2024) 144 (Supplement 1): 556.
https://doi.org/10.1182/blood-2024-210969
Published: 2024
Journal Articles

Unmet Needs in People with Hemophilia Receiving Prophylaxis Treatment: A Real-World Survey

Lynn Malec, Hanna Salehi, Nathan Ball, Sophie Lai, Marion Afonso
Journal: Blood
Blood (2024) 144 (Supplement 1): 2314.
https://doi.org/10.1182/blood-2024-204490
Published: 2024
Journal Articles

Clinical Outcomes over 2 Years of Once-Weekly Efanesoctocog Alfa Treatment in Children with Severe Hemophilia A: Second Interim Analysis from the Phase 3 XTEND-ed Long-Term Extension Study

Lynn Malec, Beatrice Nolan, Anthony K C Chan, Manuela Albisetti, Sheng-Chieh Chou, Bulent Zulfikar, Mindy Simpson, Liqi Feng, Helena Palmborg, Graham Neill, Lydia Abad-Franch, Sriya Gunawardena, Karin Fijnvandraat
Journal: Blood
Blood (2024) 144 (Supplement 1): 5495.
https://doi.org/10.1182/blood-2024-206915
Published: 2024
Journal Articles

Experiences with Efanesoctocog Alfa: Exit Interviews with Caregivers of Previously Treated Patients with Hemophilia A from the XTEND-Kids Phase 3 Clinical Trial

Lynn Malec, Manuel Carcao, Mary Mathias, Nana Kragh, Jennifer Dumont, Annemieke Willemze, Linda Bystrická, Amanda Wilson, Dana Dibenedetti
Journal: Blood
Blood (2023) 142 (Supplement 1): 507.
https://doi.org/10.1182/blood-2023-181973
Published: 2023
Journal Articles

Treatment of Bleeding Episodes with Efanesoctocog Alfa in Children with Severe Hemophilia A in the XTEND-Kids Phase 3 Study

Lynn Malec, Amy Dunn, Manuel Carcao, Bulent Zulfikar, Ruben Berrueco, Simon Brown, Umer Khan, Sriya Gunawardena, Graham Neill, Lydia Abad-Franch, Linda Bystrická, Elena Santagostino, Sophie Susen
Journal: Blood
Blood (2023) 142 (Supplement 1): 3993.
https://doi.org/10.1182/blood-2023-188739
Published: 2023
Journal Articles

Hemophilia A Research Program (HARP): A Novel Study Design for a Multicenter and Decentralized Prospective Observational Longitudinal Cohort Study in Hemophilia A

Jill M Johnsen, Shannon L Meeks, Grier P Page, Bhavya S Doshi, Marian T Sullivan, Mary-Anne Ardini, Angela C Weyand, Lynn Malec
Journal: Blood
Blood (2023) 142 (Supplement 1): 5494.
https://doi.org/10.1182/blood-2023-191010
Published: 2023
Journal Articles

Gene Therapy Expressing Platelet-Derived Factor VIII for Correction of Hemophilia Α with a History of Inhibitors

David A. Wilcox, Myriam Armant, Lynn Malec, Qizhen Shi, Bryon D. Johnson, Huiqing Xu, Lily M. Du, Lisa J. Duffy, Frederic D. Bushman, James H. Jerkins, Peiman Hematti, Ruta Brazauskas, Shawn M. Jobe, Parameswaran N. Hari, Mary Eapen
Journal: Blood
Blood (2023) 142 (Supplement 1): 2249.
https://doi.org/10.1182/blood-2023-172845
Published: 2023
Journal Articles

Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study

Clinical Trials & Observations
Lynn Malec, An Van Damme, Anthony K. C. Chan, Mariya Spasova, Nisha Jain, Charlotte Sensinger, Jennifer Dumont, Stefan Lethagen, Manuel Carcao, Flora Peyvandi
Journal: Blood
Blood (2023) 141 (16): 1982–1989.
https://doi.org/10.1182/blood.2022017780
Published: 2023
Includes: Supplemental data
Journal Articles

Multicenter, Randomized Crossover Trial Comparing Recombinant Von Willebrand Factor and Tranexamic Acid for Heavy Menstrual Bleeding in Von Willebrand Disease

Margaret V. Ragni, Scott Rothenberger, Robert Feldman, Danielle Nance, Andrew D Leavitt, Lynn Malec, Robert F. Sidonio, Jr., Eric H. Kraut, Joseph L Lasky, III, Claire S. Philipp, Dana E. Angelini, Rajiv K. Pruthi, Nina Hwang, Allison P. Wheeler, Roshni Kulkarni, Craig D. Seaman, Frederico Xavier, Nicoletta C Machin, Michael Meyer, Daniel Bellissimo, Kenneth J. Smith, Elizabeth P. Merricks, Timothy C. Nichols, Dana Ivanco, Deborah Vehec, Glory Koerbel, Andrew D. Althouse
Journal: Blood
Blood (2022) 140 (Supplement 1): 1413–1415.
https://doi.org/10.1182/blood-2022-156921
Published: 2022
Journal Articles

U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Study): Inhibitor Development and Treatment Characteristics

Shannon L Carpenter, Martin Chandler, Michael F Guerrera, Lynn Malec, Matthew Manuel, Michael Recht, Ulrike Reiss, Robert F. Sidonio, Jr., Cristina Tarango, Marijke Van den Berg, Michael Wang, Courtney D. Thornburg
Journal: Blood
Blood (2022) 140 (Supplement 1): 63–64.
https://doi.org/10.1182/blood-2022-162660
Published: 2022
Journal Articles

Efficacy of rFVIIIFc for First-Time Immune Tolerance Induction (ITI) Therapy: Final Results from the Global, Prospective VerITI-8 Study

Lynn Malec, An Van Damme, Anthony Chan, Mariya Spasova, Nisha Jain, Charlotte Sensinger, Jennifer Dumont, Stefan Lethagen, Manuel Carcao, Flora Peyvandi
Journal: Blood
Blood (2021) 138 (Supplement 2): LBA-5.
https://doi.org/10.1182/blood-2021-155156
Published: 2021